# Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl.

> **NCT01265888** · PHASE2 · COMPLETED · sponsor: **Geno LLC** · enrollment: 31 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension
- Idiopathic Pulmonary Fibrosis

## Interventions

- **DRUG:** Inhaled Nitric Oxide
- **DRUG:** Inhaled Nitric Oxide
- **DRUG:** Inhaled Nitric Oxide

## Key facts

- **NCT ID:** NCT01265888
- **Lead sponsor:** Geno LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2016-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01265888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01265888, "Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01265888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*